Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The current public-health risk is low, but the CDC is working with states to monitor people with animal exposure.

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the ...

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...

Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) ...

The company's newer product, an RSV ( respiratory syncytial virus) vaccine, has also underperformed, contributing "minimal ...

Shares of Moderna plunged 20% Monday after the vaccine maker slashed its forecast of full-year 2025 revenue, as sales of its ...

Shares of Moderna tumbled Monday after the vaccine maker predicted a steeper-than-expected sales drop in the new year.

Moderna receives $590M contract from HHS for mRNA-based bird flu vaccine; up 4% in after-hours trading. Read more here.

Moderna's been anything but a high-flying growth stock in this investor's portfolio. So is it high time he gave up on this ...

The main reason for this week's decline is that Moderna lowered its 2025 full-year revenue guidance, and by a wide margin.